|
|
|
|
LEADER |
00000cam a2200000M 4500 |
001 |
EBSCO_ocn823283784 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr un|---uuuuu |
008 |
121202s2012 xx ob 001 0 eng d |
040 |
|
|
|a IDEBK
|b eng
|e pn
|c IDEBK
|d MERUC
|d YDXCP
|d N$T
|d MHW
|d E7B
|d NLGGC
|d OCLCQ
|d NKT
|d OCLCQ
|d D6H
|d OCLCQ
|d JBG
|d ZCU
|d OCLCF
|d OCLCO
|d VNS
|d OCLCO
|d VTS
|d ICG
|d OCLCQ
|d TKN
|d STF
|d DKC
|d OCLCO
|d OCLCQ
|d K6U
|d OCLCA
|d ESU
|d RC0
|d CN6UV
|d DGN
|d AJS
|d M8D
|d SDF
|d HS0
|d OCLCO
|d SGP
|d GPRCL
|d OCLCQ
|d DXU
|
066 |
|
|
|c (S
|
019 |
|
|
|a 819070465
|a 821180478
|a 1264838718
|
020 |
|
|
|a 1283850672
|
020 |
|
|
|a 9781283850674
|
020 |
|
|
|a 9789814299794
|
020 |
|
|
|a 9814299790
|
020 |
|
|
|z 9789814299787
|q (hardcover ;
|q alk. paper)
|
020 |
|
|
|z 9814299782
|q (hardcover ;
|q alk. paper)
|
029 |
1 |
|
|a AU@
|b 000052353539
|
029 |
1 |
|
|a AU@
|b 000054843215
|
029 |
1 |
|
|a DEBBG
|b BV043082735
|
029 |
1 |
|
|a DEBBG
|b BV043774539
|
029 |
1 |
|
|a DEBBG
|b BV044171166
|
029 |
1 |
|
|a DEBSZ
|b 424593513
|
029 |
1 |
|
|a DKDLA
|b 820120-katalog:000672390
|
029 |
1 |
|
|a NZ1
|b 14795340
|
029 |
1 |
|
|a NZ1
|b 15586950
|
035 |
|
|
|a (OCoLC)823283784
|z (OCoLC)819070465
|z (OCoLC)821180478
|z (OCoLC)1264838718
|
050 |
|
4 |
|a RC848.H44 .S384 2012
|
060 |
|
4 |
|a WC 536
|
072 |
|
7 |
|a PSGL
|2 bicssc
|
072 |
|
7 |
|a MED
|x 114000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.3623
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Chronic Hepatitis B AND C :
|b Basic Science to Clinical Applications.
|
260 |
|
|
|b World Scientific Publishing Co.
|c 2012.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
520 |
|
|
|a The scope of the book is very broad, covering a wide range of areas in HBV/HDV and HCV research, including both basic and clinical science. The selected topics range from epidemiology, immunology, molecular virology and oncology, to clinical therapy. Chronic Hepatitis B and C consists of 14 chapters, each being a review of a special topic on HBV or HCV. While review articles on a special topic can be found in periodical journals, they tend to be more restricted in presentation. Therefore, this book will provide more in-depth coverage of what are presented as "unpublished results" and "data not shown" in journal articles. Furthermore, several authors in this book do not write review articles regularly. Some authors wrote reviews on a specific topic regularly, but they tried a new topic in this book (e.g., Dr. YF Liaw on "natural course," Dr. Shih on "virion release," Dr. Michael Lai on "lymphotropism of HCV," etc.?). Overall, the book will offer useful information at the cutting age.
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Natural course of chronic hepatitis B virus infection / Chia-Ming Chu and Yun-Fan Liaw -- Immune response and viral hepatitis B / David R. Milich -- Epidemiology of viral hepatitis B-related hepatocellular carcinoma / McGlynn, K.A., Evans, A.A. and W. Thomas London -- Molecular biology of HBV-related hepatocellular carcinoma / Amanda J. Hodgson and Betty L. Slagle -- Treatment of chronic viral hepatitis B and drug resistant variants / Tin Nguyen, Paul Desmond and Stephen Locarnini -- Virion secretion of naturally occurring core antigen variants of human hepatitis B virus / Chiaho Shih -- Recent developments in hepatitis delta virus / Camille Sureau -- Development of an HCV cell culture system / Takanobu Kato and Takaji Wakita -- Regulation of innate immunity and interferon defenses by hepatitis C virus / Stacy M. Horner and Michael Gale Jr -- Expression and functions of hepatitis C virus F protein / Kamile Yuksek and Jing-hsiung James Ou -- Lymphotropism of hepatitis C virus / Keigo Machida and Michael M.C. Lai -- Host genetic factors control hepatitis C virus infection / Yasuhito Tanaka and Masashi Mizokami -- Treatment of hepatitis C virus infection : past, present, and future / Chun-Jen Liu, Ding-Shinn Chen -- Individualized therapy for chronic hepatitis C / Ming-Lung Yu, Wan-Long Chuang.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Hepatitis B
|x Pathophysiology.
|
650 |
|
0 |
|a Hepatitis C
|x Pathophysiology.
|
650 |
|
0 |
|a Chronic diseases.
|
650 |
|
0 |
|a Hepatitis B
|x Treatment.
|
650 |
|
0 |
|a Hepatitis C
|x Treatment.
|
650 |
|
2 |
|a Hepatitis B
|x physiopathology
|
650 |
|
2 |
|a Hepatitis C
|x physiopathology
|
650 |
|
2 |
|a Chronic Disease
|
650 |
|
2 |
|a Hepatitis B
|x therapy
|
650 |
|
2 |
|a Hepatitis C
|x therapy
|
650 |
|
6 |
|a Hépatite B
|x Physiopathologie.
|
650 |
|
6 |
|a Hépatite C
|x Physiopathologie.
|
650 |
|
6 |
|a Maladies chroniques.
|
650 |
|
6 |
|a Hépatite B
|x Traitement.
|
650 |
|
6 |
|a Hépatite C
|x Traitement.
|
650 |
|
7 |
|a MEDICAL
|x Hepatology.
|2 bisacsh
|
650 |
|
7 |
|a Chronic diseases.
|2 fast
|0 (OCoLC)fst00860072
|
650 |
|
7 |
|a Hepatitis C
|x Treatment.
|2 fast
|0 (OCoLC)fst00955216
|
720 |
|
|
|a SHIH CHIAHO.
|
776 |
0 |
8 |
|i Print version:
|a Shih, Chiaho.
|t CHRONIC HEPATITIS B AND C : BASIC SCIENCE TO CLINICAL APPLICATIONS.
|d Singapore : World Scientific, ©2012
|z 9789814299787
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=504171
|z Texto completo
|
880 |
8 |
|
|6 505-00
|a Acknowledgments -- References -- Chapter 9 Regulation of Innate Immunity and Interferon Defenses by Hepatitis C Virus Stacy M. Horner and Michael Gale Jr -- Introduction -- Hepatocytes Detect HCV Infection Through RIG-I -- Actions of PRRs -- HCV is Recognized as Non-Self by RIG-I -- Molecular Mechanism of RIG-I Activation -- IFN Signaling During HCV Infection -- Control of Innate Immune Signaling by HCV -- HCV Disruption of IFN- β Induction -- Regulation of the RIG-I Pathway -- HCV Regulation of IFN Signaling and Antiviral Activities of IFN-Induced Proteins -- Conclusion and considerations -- Summary -- Acknowledgments -- References -- Chapter 10 Expression and Functions of Hepatitis C Virus F Protein Kamile Yuksek and Jing-hsiung James Ou -- Introduction -- The Discovery of the HCV F Protein -- Expression of the F Protein During Natural Infection -- Molecular Mechanisms for the Expression of the HCV F Protein -- Expression by Programmed Ribosomal Frameshift -- Expression of the F Protein by Translation Initiation from Internal AUG Codons -- Expression of the F Protein from a Non-AUG Codon -- Biological Functions of the F Protein -- Interaction between the F Protein and the Proteasome -- Regulation of Expression of Cytokines by the F Protein -- Possible Role of the F Protein in Hepatocellular Carcinogenesis -- HCV F Protein and Microtubules -- Conclusion -- References -- Chapter 11 Lymphotropism of Hepatitis C Virus Keigo Machida and Michael M.C. Lai -- 1. Introduction -- 2. Review of Evidence for Extrahepatic Infection of HCV -- 2.1. Epidemiological Evidence for the HCV Infection of B and T Cells in Hepatitis C Patients -- 2.2. Epidemiological Association Between HCV Infection and Lymphoma -- 2.3. Evidence Negating the Association between HCV Infection and Lymphoma.
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10627497
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 504171
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 416317
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 7583602
|
994 |
|
|
|a 92
|b IZTAP
|